Psychiatry and Neuroscience Update

<p>PART 1: EPISTEMOLOGICAL CONSIDERATIONS ABOUT THE STUDY OF NORMAL AND ABNORMAL HUMAN BEHAVIORS</p><p> </p><p>1. Knowledge, by Philosophy or Science? Psychotherapy or Neuroscience?</p><p>Humberto Luis Mesones-Arroyo</p><p> </p><p>2. Phenomenology as an approach method in the Neurosciences</p><p>Ivana Antón Mlinar</p><p> </p><p>3. Trends in Philosophy of Mind and in Philosophy of Neuroscience</p><p>Juan José Sanguineti</p><p> </p><p>4. Neurosciences, Neuroeconomics, and Metaphysics</p><p>Ricardo F. Crespo, PhD</p><p> </p><p>5. Towards a Psychotherapy with a Philosophical Basis</p><p>Ricardo Aranovich</p><p> </p><p>6. DSM5: A Bioethical Overview </p><p>Gilberto A. Gamboa-Bernal</p><p> </p><p> </p><p> </p><p>PART 2: FROM BASIC NEUROSCIENCES TO HUMAN BRAIN</p><p> </p><p>7.  Brain Renin-Angiotensin System: A Novel Therapeutic Target for Psychostimulant and Alcohol Related Disorders?</p><p>M. Constanza Paz, Natalia A. Marchese, Claudia Bregonzio, and Gustavo C. Baiardi</p><p> </p><p>8. Role of the Neuropeptide Angiotensin II in Stress and Related Disorders</p><p>ClaudiaBregonzio, Maria de los Angeles Marinzalda, andGustavo Baiardi </p><p> </p><p>9.  Neurovascular Cognitive Alterations: Implication of Brain Renin-Angiotensin System (Ras). Therapeutic Opportunities and Risk Factors</p><p>Natalia Andrea Marchese, Brenda Solange Casarsa, Gustavo Baiardi, and Claudia Bregonzio</p><p> </p><p>10. Prevention of Stress-Induced Cognitive Impairment: Today and Tomorrow</p><p>Emil Trofimiuk and Jan J. Braszko</p><p> </p><p>11. Circadian Synchronization of Cognitive Functions</p><p>Ana Cecilia Anzulovich-Miranda</p><p> </p><p>12. The Role of Iron and Other Trace Elements on Mental Development and Cognitive Function</p><p>Silvia Izquierdo Álvarez, Eloísa Urrechaga Igartua, Maria Teresa Llorente Ballesteros,  and Jesús Fernando Escanero Marcén</p><p> </p><p>13. New Insights in Glutamate-Mediated Mechanisms Underlying Benzodiazepines Dependence and Cocaine Vulnerability</p><p>Emilce Artur de la Villarmois, Laura A. Gabach and Mariela F. Pérez</p><p> </p><p>14. Soy and Psychotropic Effects: A Brief Overview</p><p>Rose E. Nina-Estrella</p><p> </p><p>15. Use of Psychotropic Drugs: Between the Medicalization and Rationality</p><p>Alicia Panini, Marisa Garraza, Mauricio Teves, Emiliano Giraudo, Claudia Calderón</p><p> </p><p> </p><p> </p><p>PART 3: NEUROSCIENCES, LEARNING, TEACHING AND THE ROLE OF SOCIAL ENVIRONMENT</p><p> </p>16. Learning Styles: From Basic Investigation to Learning in the Classroom.Gabriela Díaz-Véliz<p> </p><p>17. Learning Styles and Strategies: The Importance of the Tool Selection</p><p>Jesús Fernando Escanero Marcén, Marisol Soria Aznar, Manuel Guerra Sánchez, Jackson Silva and Pascual Angel Gargiulo</p><p> </p><p>18. Attentional Capacity in Children: Intervention Programmes for its Development</p><p>Mirta Susana Ison</p><p> </p><p>19. Social Representation and Imagery of Labor.</p><p>Evaluation Process of the Psychosocial and Labor Vulnerability (PSLV) and its Relation With Mental Health</p><p>Carlos Bonantini,  Mauricio Cervigni,  Melisa Mandolesi, Victor Quiroga, and Miguel Gallegos </p><p> </p><p> </p><p> </p><p>PART 4: EXPLAINING HUMAN PATHOLOGICAL BEHAVIORS: FROM BRAIN DISORDERS TO PSYCHOPATHOLOGY</p><p> </p><p>20. The Ying and Yang of Pain: Protective vs. Damaging</p><p>Cristian G. Acosta</p><p> </p><p> </p><p>21. Neuropsychological Disorders after Mild Traumatic Brain Injury or Concussion</p><p>G. Bermúdez and .V. Lafuente</p><p> </p><p>22. Animal Models of psychopathology and its relation to clinical practice<p>Amauri Gouveia and Thiago Marques de Brito  </p><p> </p><p>23.  Biological Markers in Psychiatry and its Relation with Translational Approaches: </p><p>Brief Historical Review</p><p>Ángel José Martín Gargiulo, Mercedes María Lucrecia Gargiulo, Augusto Pascual Ítalo Gargiulo, Gonzalo Mesones, Gustavo Martin, Adriana Inés Landa de Gargiulo, Humberto L. Mesones, and Pascual Ángel Gargiulo</p><p> </p><p>24. ‘Two Hit’ Neurodevelopmental Mechanisms In Schizophrenia: Focus On Animal Models And The Role Of BDNF</p><p>Maren Klug, Rachel Hill, and Maarten Van den Buuse</p><p> </p><p>25. Translating the Glutamatergic Hypothesis of Schizophrenia through Homeostatic Regulation of Brain Glycine</p><p>Sylvain Dubroqua, Philipp Singer, Benjamin K. Yee</p><p> </p><p>26. Adenosine in the neurobiology of schizophrenia: potential adenosine receptor-based pharmacotherapy </p><p>Francisco Ciruela, Víctor Fernández-Dueñas, Fernando Contreras, Josep M. Arnau, José Manuel Menchón, Antoni Vallano, Marta Valle-León</p><p> </p><p>27. Mindfulness and Neuroimaging</p><p>Nicolás Fayed, Ignacio Cifre, Javier Garcia-Campayo, and Laura Viguera</p><p> </p><p>28. Clinical Magnetic Resonance Neuroimaging in Mild Cognitive Impairment and Alzheimer´s Disease</p><p>Nicolás Fayed,Javier Garcia-Campayo, and Laura Viguera</p><p> </p>